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Abstract
Introduction: This study assessed whether mesenchymal stem cell (MSC)-derived extracellular vesicles influenced
ageing and pluripotency markers in cell cultures where they are added.
Methods: MSC-derived extracellular vesicles from old and young rat bone marrows were isolated by
ultracentrifugation and were characterised by western blotting, nanoparticle tracking analysis (NTA) and
transmission electron microscopy (TEM). They were added to young and old MSC cultures. Real-time quantitative
reverse transcription polymerase chain reactions and western blot analysis were performed to check the markers of
ageing (vinculin and lamin A), pluripotency markers (Nanog and Oct4) and components of the mTOR signalling
pathway (Rictor, Raptor, AKT and mTOR) in these cell populations. Subsequently, microRNA (miR)-188-3p expression
was transiently inhibited in young MSCs to demonstrate the influence of mTOR2 on MSC ageing.
Results: Incubation with young MSC-derived extracellular vesicles decreased the levels of ageing markers and
components of the mTOR pathway and increased the pluripotency markers from old MSC populations. By contrast,
incubation of young MSCs with old MSC-derived extracellular vesicles generated the reverse effects. Inhibition of
miR-188-3p expression in young MSCs produced extracellular vesicles that when incubated with old MSCs
produced an increase in the levels of Rictor, as well as a decrease of phosphor-AKT, as indicated by a significant
decrease in beta-galactosidase staining.
Conclusions: MSC-derived extracellular vesicles affected the behaviour of MSC cultures, based on their
composition, which could be modified in vitro. These experiments represented the basis for the development of
new therapies against ageing-associated diseases using MSC-derived extracellular vesicles.
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Introduction
Cellular senescence, the result of complex phenotypic
changes and ageing, constitutes a great risk factor that con-
tributes to trigger different degenerative diseases. Unravel-
ling the importance of the effect of ageing on mesenchymal
stem cells (MSCs) is crucial in the development of new
therapy based on these cells, focusing on the treatment of
older people. The beneficial effects on damaged tissues are
attributed to the paracrine activity of the MSCs, which in-
clude their soluble factors and extracellular vesicles (EVs).
An interesting study indicated that MSC-derived EVs have
significant potential as a novel alternative to whole-cell
therapies in an experimental preclinical model of the in-
flammatory lung [1]. EVs transport mRNA, microRNA
(miRNA) and proteins giving them the possibility of trans-
porting biological information to the surrounding cells [2].
Previous results by our group indicated that proliferative,
pluripotency and metabolism profiles of MSCs have
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significant differences influenced by the donor age [3]. We
also demonstrated that immune profiles of MSC-derived
EVs have age-dependent differences and they can be modi-
fied using miRNA [4]. The mammalian target of rapamycin
(mTOR) is an amino acid sensor which perceives and in-
corporates different environmental signals. mTOR balances
cell growth and nutrient availability and contributes to deci-
sions on stem cell fate as a consequence of endogenous
DNA damage [4]. mTOR also regulates cellular senescence
and drives the infrastructure of bioenergetics [5]. Rapamy-
cin inhibits the senescence effect produced by mTOR,
which is mediating MSC proliferation potential through its
effect on their self-renewal loss [6]. There are two signalling
complexes, mTOR complex 1 (mTORC1) and mTOR
complex 2 (mTORC2). mTORC2 plays an important role
in endothelial senescence, evident by an increase in binding
of Rictor, which is an essential component of mTORC2-
directed phosphorylation of mTOR at Ser2481 and AKT
(phosphor-AKT), producing an increase of β-galactosidase
staining in senescence [7]. MicroRNA (miR)-188-3p has
been shown to be a key regulator of age-associated bone
loss in the bone marrow through its target on Rictor [8],
and insights into the mechanism involved in MSC ageing
suggest that interventions with miRNAs could modify the
function of MSCs and their derived extracellular vesicles
[4]. This study assessed whether EVs could modify MSC
markers of ageing in vitro and whether Rictor has a key role
through the mTORC2 pathway involving the ageing
process.
Material and methods
Isolation and culture of MSCs
Animals were anesthetised with Fluorane (Izasa, A Cor-
uña, Spain) and euthanised by the cervical dislocation
method. The femoral bones were dissected from male
Wistar rats (Animal Service, CHUAC, Spain) at different
ages, young (14 days old) and old (270 days old). All
methods were carried out following the approved guide-
lines of the Spanish Law (32/2007). All experimental
protocols were approved by the Animal Ethical Commit-
tee of Galicia. The protocol published by Karaoz et al.
[1] was used in this work. Briefly, the ends of the fem-
oral bones were cut away, and a 21-gauge needle
inserted into the shaft of the bone marrow was extruded
by flushing with 4 ml D-Hank’s solution supplemented
with 100 IU/ml penicillin-100 mg/ml streptomycin (Life
Technologies, Madrid, Spain). The marrow plug suspen-
sion was dispersed by pipetting and filtered through a
70-μm mesh nylon filter (BD Biosciences, Bedford, MA,
USA), successively centrifuged at 2000g for 10 min. The
supernatant containing haematopoietic cells was dis-
carded, and the cell pellet was resuspended in Roswell
Park Memorial Institute (RPMI) medium supplemented
with 10% (v/v) foetal bovine serum (FBS), 1% (v/v)
penicillin and 1% (v/v) streptomycin (Life Technologies,
Madrid, Spain). The MSCs were plated into 100-cm2
dish plates (Corning Inc., NY, USA) and incubated at
37 °C in a humidified atmosphere of 5% CO2. MSCs
were isolated because of their ability to adhere to the
culture plates. On the third day, red blood cells and
other non-adherent cells were removed by a pre-plating
technique, and fresh medium was added to allow further
growth to the MSCs. The adherent MSCs grown to 70%
confluence were defined as passage 0 (P0) cells. The cul-
ture medium was replaced every 3 or 4 days. MSCs were
expanded for two passages before being used in the ex-
periments. In 6-well plates (Corning Inc., NY, USA),
2.5 × 105 MSCs from old individuals were cultured per
well for 8 h, and 2 × 107 particles of MSC-derived EVs
from young individuals were added to these wells, and
vice versa. MSCs were collected after 2, 3 and 6 days in
culture with different MSC-derived EVs, and RNA and
protein isolations were performed. Young MSCs were
incubated with 40 nM miR-188-3p miRVAna™ inhibitor
or 40 nM control negative miRVAna™ Mimic using the
expression system and protocols of the manufacturer.
Validation by reverse transcription polymerase chain re-
action (RT-PCR) was done using TaqMan® MicroRNA
Assays following the instructions of the manufacturer
(Ambion, Applied Biosystems, Madrid, Spain). MSC cul-
tures without added MSC-derived EVs were used as a
control in all the experiments.
Flow cytometry
To characterise the MSCs, they were washed twice in
phosphate-buffered saline (PBS; Sigma-Aldrich, St. Louis,
MO, USA) then pre-blocked with 2% rat serum in PBS.
The following direct antibodies were used: phycoerythrin
(PE)-conjugated mouse anti-human CD34 (1:20; DakoCy-
tomation, Barcelona, Spain), fluorescein isothiocyanate
(FITC)-conjugated mouse anti-rat CD45 (1:20; BD Phar-
mingen, Franklin Lakes, NJ, USA), PE-cyanine (Cy)5.5-
conjugated mouse anti-rat CD90 (1:20; Immunostep,
Salamanca, Spain) and allophycocyanin (APC)-conjugated
mouse anti-rat CD29 (1:20; Immunostep, Salamanca,
Spain). The cells were washed with PBS after 1 h of
incubation with the corresponding antibody at room
temperature. Fluorescence-activated cell sorting (FACS)
data was generated by BD FACSDiva software (BD Sci-
ence, San Jose, CA, USA). Negative control staining was
performed using FITC-conjugated mouse IgG1K isotype,
PE-conjugated mouse IgG1K isotype, PE-Cy5.5-conju-
gated mouse IgG1K isotype and APC-conjugated mouse
IgG1K isotype (BD Pharmingen, Franklin Lakes, NJ, USA).
Isolation of MSC-derived EVs
MSCs from young (14 days) and old (270 days) rats
were cultured with RPMI 1640 medium with
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GlutaMAX™ supplement, 10% exosome-depleted FBS
(Thermo Fisher Scientific, Waltham, MA, USA) and
100 IU/ml penicillin-100 mg/ml streptomycin (Life
Technologies, Madrid, Spain). Cells were cultured to
80% confluence, and the supernatants were collected
after 48 h. Supernatants were centrifuged at 2000×g for
10 min at 4 °C and filtered using a sterile 0.22-μm filter
(GE Healthcare Life Sciences, Little Chalfont, UK) to
eliminate debris, and they were transferred into new
ultracentrifugation tubes (Beckman Coulter, Missis-
sauga, Canada) and centrifuged at 100,000×g for 2 h at
4 °C in an Optimal-90K ultracentrifuge with a 60 Ti
rotor (Beckman Coulter, Mississauga, Canada). The last
supernatants containing exosome-depleted FBS were
removed, and the pellets were resuspended in 200 μl
PBS (MP Biomedicals, Illkrich-Graffenstaden, France).
Nanoparticle tracking analysis of MSC-derived EVs
The Brownian motion of the particles in a NanoSight
LM12 using Nanoparticle Tracking Analysis 2.3 software
(NanoSight Ltd., Amesbury, UK) was used to calculate
the EV size distribution after the ultracentrifugation.
Total protein concentrations in MSC-derived EVs were
determined with a Micro-bicinchoninic acid (BCA) kit
(Thermo Fisher Scientific, Rockford, IL, USA), according
to the manufacturer’s instructions.
Electron microscopy
MSC-derived EVs were concentrated using Vivaspin con-
centrators (Sartorius, Gottingen, Germany). They were
gathered up in small volumes of deionised water, which
were then placed on nickel grids and allowed to dry for
45min at 37 °C. The grids with MSC-derived EVs were
fixed with 4% (w/v) paraformaldehyde (Sigma-Aldrich, St.
Louis, MO, USA) for 10min and then washed by dipping
them onto several drops of deionised water. The grids
were examined on a Jeol JEM1400 transmission electron
microscope (Jeol Ltd., Tokyo, Japan).
Fluorescence microscopy
MSCs (2.5 × 105) from old and young individuals were
cultured on slides (Sigma-Aldrich, St. Louis, MO, USA)
pre-treated with poly-D-lysine (Sigma-Aldrich, St. Louis,
MO, USA) in 6-well plates (Corning Inc., New York,
NY, USA) for 8 h (day 1). MSC-derived EVs (2 × 107)
from young and old individuals were stained with 10 μM
3-3′-diethylthiacarbocyanineiodide (DiI) and added to
each culture of MSCs; PBS (MP Biomedicals, Illkrich-
Graffenstaden, France) was added as a control. At 2, 3
and 6 days, the cells were washed three times with PBS
(MP Biomedicals, Illkrich-Graffenstaden, France) and
fixed with 4% (w/v) paraformaldehyde (Sigma-Aldrich,
St. Louis, MO, USA) for 10 min, and then the slides
were mounted using ProLong® Gold antifade mountant
with 4′,6-diamidino-2-phenylindole (DAPI; (Thermo
Fisher Scientific, Carlsbad, CA, USA). The cells were ex-
amined with an Olympus BX61 microscope using a
DP71 digital chamber (Olympus, Tokyo, Japan) with
software DP-Controller and DP-Manager software. A
NeoScope JCM-6000 Plus scanning electron microscope
(Nikon-Izasa, Barcelona, Spain) was used to take supple-
mentary images.
Reverse transcription quantitative PCR analysis
Total RNA from culture cells was isolated with TRIzol® re-
agent (Thermo Fisher Scientific, Waltham, MA, USA). For
miRNA detection, cDNA was generated from DNaseI-
treated RNA, using a QuantiMir RT Kit (System Biosci-
ences, Palo Alto, CA, USA), according to the manufac-
turer’s instructions. PCR products were amplified using
specific primers for miRNAs, mmu-miR-188-3p and U6
small nuclear RNA (Thermo Fisher Scientific, Waltham,
MA, USA). The amplification programme consisted of an
initial denaturation at 50 °C for 2min, followed by 95 °C
for 10min, and 50 cycles of annealing at 95 °C for 15 s and
extension at 60 °C for 1min. Primers for the amplification
of rat genes are described in Table 1. The amplification
programme consisted of an initial denaturation at 92 °C
Table 1 Specific primers for real-time reverse transcriptase polymerase chain reaction (RT-PCR) amplification, listed with their
annealing temperature (AT)
Gene name Fw primer Rv primer mRNA ID AT (°C)
Nanog atgcctcacacggagactgt aagtgggttgtttgcctttg NM_005103.4 61
Oct4 ctcctggagggccaggaatc atatacacaggccgatgtgg NM_00510 61
Vinculin aggagaccttgcgaagacagg gcggttgccacttgtttag NM_001107248 61
LMNA gagcaaagtgcgtgaggagt tccccctccttcttggtatt NM_001002016.2 61
mTOR atcaagcaagcgacatctca caggccttggttaccagaaa NM_019906.1 61
AKT gacgtagccattgtgaaggag ccatcattcttgaggaggaagt NM_033230.2 61
Rictor gttggaaaaatggcacaagg ctgtatgtagtgagggcttcgtt NC_005101.4 61
HPRT agccgaccggttctgtcat agccgaccggttctgtca NM_012583.2 61
Fw forward, Rv reverse
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for 2min, followed by 40 cycles of annealing at 95 °C for
15 s; annealing at 55–62 °C, depending on the gene, for 30
s; and extension at 72 °C for 15 s. PCRs were done in trip-
licate, with each set of assays repeated three times. To
minimise the effects of unequal quantities of starting RNA
and to eliminate potential sources of inconsistency, rela-
tive expression levels of each gene were normalised to
ribosomal protein (HPTR) or U6 small nuclear RNA using
the 2−ΔΔCT method x[9]. Control experiments utilised
no reverse transcriptase.
Immunoblot analysis
Immunoblot analysis was performed with 40 μg total pro-
tein extracted from MSCs or 20 μg total protein extracted
from MSC-derived EVs. Proteins were separated accord-
ing to their molecular weight using sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE),
with the percentage (w/v) bis-acrylamide (Sigma-Aldrich,
St. Louis, USA) of the resolving gels being determined by
the size of the proteins. Proteins were then transferred to
nitrocellulose membranes using a semi-dry method, using
buffer with 20% (v/v) methanol (Panreac, Barcelona,
Spain) for small proteins (< 100 kDa) or 10% (v/v) metha-
nol (Panreac, Barcelona, Spain) for large proteins (> 100
kDa). Nitrocellulose membranes were then incubated for
1 h with agitation at room temperature in blocking buffer,
consisting of 5% (w/v) bovine serum albumin (BSA) for
phospho-proteins and 5% (w/v) milk (Sigma-Aldrich, St.
Louis, USA). The membranes were probed with anti-
bodies diluted in blocking buffer at 4 °C overnight. The
following day, the membranes were washed three times
for 5 min with Tris-buffered saline with 0.1% (v/v) Tween®
20 (TBST). The membranes were then incubated for 1 h
at room temperature in horseradish peroxidase (HRP)-
conjugated secondary antibodies diluted in blocking buf-
fer. Next, the membranes were washed three times in
TBST buffer for 5 min with agitation and twice using
Tris-buffered saline (TBS) for 5 min with agitation. An
Fig. 1 Characterisation of MSCs from the rat bone marrow at several ages. a One representative fluorescence-activated cell sorting (FACS) assay is
shown for old MSCs and young MSCs. The antibody is indicated at the top of each plot and its linked fluorochrome at the bottom. b The plot
shows the percentage of positive MSC markers (CD29 and CD90) and negative haematopoietic markers (CD34 and CD45). c Representative
images (magnification, × 20) of old and young MSCs
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Amersham ECL Western Blotting Analysis System (GE
Healthcare, Little Chalfont, UK) was used to visualise
protein-binding antibodies. The blots were probed with
antibodies directed against LMNA/C (Acrix); mTOR, Ric-
tor, phosphor-mTOR, AKT and phosphor-AKT (Cell Sig-
naling Technology, Beverly, MA, USA); Tsg101, calnexin
and CD63 (Abcam, Cambridge, MA, USA); and β-actin
(Sigma-Aldrich, St. Louis, MO, USA). Adequate concen-
trations for each antibody were determined empirically.
Blot images were digitised using a LAS 3000 image ana-
lyser (GE Healthcare, Little Chalfont, UK). Densitometry
analysis of band intensities was performed using Image-
Quant 5.2 software (GE Healthcare, Little Chalfont, UK).
Senescence-associated beta-galactosidase staining
Cytochemical staining of senescence-associated beta-
galactosidase (SA-β-gal) with 5-bromo-4-chloro-3-indolyl-
β-D-galactopyranoside (X-Gal) was performed as previously
described [7]. Cells were fixed and then stained with freshly
prepared SA-β-gal staining solution overnight at 37 °C, ac-
cording to the manufacturer’s protocols (Cell Signaling
Technology, Beverly, MA, USA). The experiments were
conducted three times, with ten images being acquired of
each treatment using an Olympus BX61 microscope
(Olympus, Tokyo, Japan). Images were quantified with Ima-
geJ software, with the intensity of SA-β-gal staining being
expressed as arbitrary units.
Statistical analysis
All experiments were performed in triplicate, and one rep-
resentative was shown in this paper. Non-parametric stat-
istical analysis was performed by Mann-Whitney U and
Kruskal-Wallis tests using GraphPad Prism 6 (GraphPad
Software, La Jolla, USA). P values < 0.05 were considered
statistically significant. All the results were presented as
standard errors of the mean.
Fig. 2 NTA study of MSC-derived EVs at several ages. a Representative results from the NTA assay of old and young MSC-derived EVs. b Electron
micrographs of MSC-derived EVs from the old and young groups of rats (scale bar = 100 nm). c The number of particles per cell at different age
groups by NTA assay. d Concentration of protein per particle at different age groups as determined by NTA assay. e Mean size of particles,
expressed in nanometres, for different age groups as determined by NTA assay. *P < 0.05 compared with the former group was considered
statistically significant using Mann-Whitney U and Kruskal-Wallis tests. f Ponceau S staining for protein content for 20 μg MSC-derived EVs and
their immunoblot staining for exosome markers CD63, TSG101 and Calnexin
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Results
Characterisation of both young and old populations of
MSCs by flow cytometry revealed no statistically signifi-
cant differences in levels of mesenchymal and haemato-
poietic markers (Fig. 1a). Cells positive for CD45 and
CD34 represented less than 1% of cells positive for
CD29 (70 ± 5%) and cells positive for CD90 (90 ± 5%), in
all groups studied (Fig. 1b). There were no morpho-
logical differences between young and old MSCs (Fig. 1c),
with both of them presenting as spindle-shaped.
Representative graphics obtained by nanoparticle
tracking analysis (NTA) from old and young MSD-
derived EVs are shown in Fig. 2a. MSC-derived EVs
were visualised by electronic microscopy as 70–80-
nm-diameter vesicles in both old and young popula-
tions (Fig. 2b). The production of MSC-derived EVs
increased with increasing donor age in a statistically
significant way (52%; Fig. 2c). By contrast, the protein
to particle ratio of MSC-derived EVs decreased with
increasing donor age in a statistically significant way
(37.5%; (Fig. 2d). The diameter of EVs as determined
by NTA was 160 ± 18 nm and was not statistically sig-
nificantly different between the young and old groups
(Fig. 2e). Western blotting analysis indicated that the
MSC-derived EVs contained exosome-associated pro-
teins CD63 and TSG101 but not calnexin (Fig. 2f).
Internalising of old MSC-derived EVs into young
MSCs was observed after 2 days in culture, and there
was an increase in EVs inside the MSCs with time
(Fig. 3a). A similar effect was observed by fluorescence
microscopy in old MSCs co-cultured with young MSC-
derived EVs (Fig. 3b). Additional file 1: Figure S1 shows
an old MSC with its cytoplasm full of young MSC-
derived EVs, at a magnification of × 100.
Genes Nanog and Oct4, which are pluripotency markers
in MSCs, showed statistically significant increased expres-
sion in old MSCs treated with young MSC-derived EVs at
different times of incubation, compared to untreated cells
(P < 0.05; Fig. 4a). By contrast, young MSCs treated with
old MSC-derived EVs showed statistically significant lower
Nanog and Oct4 gene expression after 2 days of incubation
(P < 0.05; Fig. 4a). Vinculin, a senescence marker, had a sta-
tistically significant decrease in its expression at 6 days for
old MSCs treated with young MSC-derived EVs (P < 0.05;
Fig. 4b), while it was increased statistically in young MSCs
treated with old MSC-derived EVs (P < 0.05; Fig. 4b).
Gene LMNA and its isoforms, as well as vinculin,
which were senescence markers in MSCs, showed a sta-
tistically significant decrease in expression in old MSCs
treated with young MSC-derived EVs at different times
of incubation, compared to untreated cells (P < 0.05;
Fig. 5a). Young MSCs treated with old MSC-derived EVs
also presented with statistically higher LMNA gene ex-
pression after 2, 3 and 6 days of incubation (P < 0.05;
Fig. 5a). Validation of levels of LMNA and its isoforms
at the protein level indicated that old MSCs treated with
young MSC-derived EVs had a decrease in the expres-
sion of isoforms lamin A/C at 6 days (Fig. 5b), while
Fig. 3 Internalisation of MSC-derived EVs as observed by fluorescence microscopy. Images from fluorescence microscopy (magnification, × 40) of
the nuclei of MSCs stained with 4′,6-diamidino-2-phenylindole (DAPI) and MSC-derived EVs stained with DiI. a Old MSCs cultured with young
MSC-derived EVs at 2, 3 and 6 days. b Young MSCs cultured with old MSC-derived EVs at 2, 3 and 6 days. c Control of young MSCs and old MSCs
without added EVs. One representative experiment is shown. oMSC, MSCs from the old group; yMSC, MSCs from the young group; oEV, MSC-
derived EVs from the old group; yEV, MSC-derived EVs from the young group
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young MSCs treated with old MSC-derived EVs showed
an increased expression at 6 days (Fig. 5b).
Study of the members of the mTOR pathway revealed
statistically significant decreased expression of mTOR
(P < 0.05) in old MSCs treated with young MSC-derived
EVs, after 2 and 6 days (P < 0.05; Fig. 6a). Rictor and
AKT expression was also decreased; however, it was not
statistically significant (Fig. 6a). By contrast, in young
MSCs treated with old MSC-derived EVs, mTOR and
AKT gene expression was significantly higher (P < 0.05)
after 2, 3 and 6 days. Rictor revealed a statistically signifi-
cant decrease in expression when young MSCs were
treated with old MSC-derived EVs, after 2, 3 and 6 days
(P < 0.05; Fig. 6b). Western blot analysis indicated that
levels of phosphor-mTOR and phosphor-AKT were de-
creased in old MSCs treated with young MSC-derived
EVs, while Rictor was not detected (Fig. 6c). By contrast,
western blot analysis indicated that phosphor-mTOR
was increased in young MSCs treated with old MSC-
derived EVs. In addition, Rictor was detected in young
MSCs treated with old MSC-derived EVs after 2 days in
culture (Fig. 6d).
A statistically significant decrease in the miR-188 ex-
pression was obtained in young MSCs when treated with
the inhibitor of miR-188, compared with mimic-miR-
188 used as a control to confirm transfection efficiency
(P < 0.05; Fig. 7a). Young MSC-derived EVs-188−/− were
used to treat old MSCs, resulting in a statistically signifi-
cant increase in the Rictor expression in this population,
compared with old MSCs treated with only young MSC-
derived EVs (Fig. 7b). By contrast, the gene AKT showed
decreased expression. These results were independently
validated by western blot (Fig. 7c), where old MSCs
treated with young MSC-derived EVs-188−/− produced
an increased level of Rictor and a decreased level of
phosphor-AKT. Young MSC-derived EVs-188−/− pro-
duced a statistically significant decrease in the number
of cells staining positively for SA-β-gal (Fig. 7d).
Discussion
The current study indicated that MSC-derived EVs
might be involved in the senescence process, which
could be influenced by Rictor through mTORC2. MSCs
have been used therapeutically in regenerative medicine
Fig. 4 Study of the self-renewal potential in MSCs. a Histograms represent Nanog and Oct4 gene expression normalised with HPRT, a
housekeeping gene, in old MSCs with or without young MSC-derived EVs (upper). Histograms represent Nanog and Oct4 gene expression
normalised with HPRT, a housekeeping gene, in young MSCs with or without old MSC-derived EVs (bottom). b The histograms represent the
gene expression of vinculin normalised by HPRT, a housekeeping gene, in old MSCs with or without young MSC-derived EVs (upper). The
histograms represent the gene expression of vinculin gene expression normalised by HPRT, a housekeeping gene, in young MSCs with or without
old MSC-derived EVs (bottom). *P < 0.05 compared with the former group was considered statistically significant using Mann-Whitney U and
Kruskal-Wallis tests. Control, MSCs cultured with growth medium without EVs; oMSC, MSCs from the old group; yMSC, MSCs from the young
group; oEV, MSC-derived EVs from the old group; yEV, MSC-derived EVs from the young group
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for their differentiation and secretory potential. Biancone
et al. [2] have reported that MSCs can modulate gene
expression by releasing extracellular vesicles to maintain
physiological processes.
MSCs from two different age groups of rats were
characterised by flow cytometry (Fig. 1), and our re-
sults were consistent with those of Jin et al. [10]. All
the cells had the ability to adhere to the plastic
culture dish, which was an inherent characteristic of
MSCs, and the groups were able to differentiate to-
wards several mesoderm lineages, results that were
similar to a previously published report [11]. The size
of EVs was determined by NTA, which calculated the
size from the total concentration of vesicles in solu-
tion, following the technique used by Gercel-Taylor
et al. [12] and validated by electron microscopy
(Fig. 2b). We found an increase in the production of
MSC-derived EVs from the old group of rats com-
pared to the young group (Fig. 2c). A rational explan-
ation for this fact could be as a compensation
mechanism by old MSCs because of a decrease in
their protein to particle ratio (Fig. 2d). These results
were similar to those previously published by our
group [4]. In addition, the MSC-derived EVs were pos-
itives for CD63 and Tsg101 but negative for calnexin,
by western blot (Fig. 2f), meeting the requirements for
their definition as EVs as reported by the International
Society for Extracellular Vesicles (ISEV) [13].
There is an interesting study about the mechanisms of
EV uptake by target cells, such as endocytosis mediated by
clathrin or caveolin-dependent, macropinocytosis and
phagocytosis [5], mechanisms involving cell surface mem-
brane fusion with lipidic participation [6]. In addition, by
fluorescence microscopy, this current study demonstrated
the internalisation of MSC-derived EVs labelled with DiI,
a process that was independent of the age of the donor
(Fig. 3). These results were similar to other studies where
dendritic cells [8] and melanoma cells [14] were used. In
addition, some DiI label was observed in the extracellular
region that could represent lipids from the membranes of
MSC-derived EVs, as their lipid composition was abun-
dant in complex phosphoryl derivatives of sphingosine
and choline, which would support the plasma membrane
renewing [15]. Young MSC-derived EVs labelled with DiI
inside old MSCs is shown in Additional file 1: Figure S1.
The discovery of epigenetic mechanisms has placed
the dynamic of global chromatin centrally to the follow-
ing of pluripotency, and lineage progression of human
embryonic stem cells because of the histone deacetyla-
tion is necessary to express Oct4 and Nanog in these
cells [16]. Therefore, we performed genetic studies to
evaluate the expression of those pluripotency markers,
Fig. 5 Study of senescence in MSCs. a The histograms represent the gene expression of LMNA normalised by HPRT, a housekeeping gene, in old
and young MSCs with or without young or old MSC-derived EVs. *P < 0.05 compared with the control was considered statistically significant
using Mann-Whitney U and Kruskal-Wallis tests. Control, MSCs cultured with growth medium without EVs; oMSC, MSCs from the old group; yMSC,
MSCs from the young group; oEV, MSC-derived EVs from the old group; yEV, MSC-derived EVs from the young group. b Western blot analysis of
pre-lamin A and their isoforms, lamin A/C, from old and young MSCs with or without old or young MSC-derived EVs at different times (2, 3 and
6 days) and LMNA densitometry analysis normalised with respect to β-actin, using Image Quant 5.2. The molecular weight of each protein is
shown on the left. One representative experiment is shown. The gels have been run under the same experimental conditions
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which are important transcription factors in controlling
the expression of multiples genes associated with MSC
pluripotency pathways. Reduced expression of these
genes due to inactivation in in vitro culture under nor-
moxia [11] results in reduced proliferation and pluripo-
tency capacities [17]. It was observed that pluripotency
expression markers changed when MSCs were incubated
with MSC-derived EVs. Old MSCs showed increased ex-
pression of Nanog and Oct4 when they were cultured
with young MSC-derived EV. By contrast, young MSCs
cultured with old MSC-derived EV showed decreased
expression of these transcription factors (Fig. 4a). As
such, we confirmed that EV influenced the self-renewal
capacity of MSCs at the genetic level, consistent with Jo
et al. [18], who used a system of nanovesicles engineered
from embryonic stem cells. Merino-González et al. [19]
reported that the secretion of soluble factors and the re-
lease of extracellular vesicles, such as exosomes, could
mediate cellular communication, inducing cell differenti-
ation and self-renewal.
Vinculin gene expression was assessed in this current
study because it was involved in contractility and cellular
adhesion [20]. Vinculin is a well-characterised F-actin
binding protein localised in focal adhesions as well as in
cell-adherence junctions and undergoes changes in the
expression both at the proteomic and genetic levels in
relationship with age. A decrease in the expression of
this gene was observed in old MSC cultured with young
MSC-derived EVs, while an increase was found in young
MSCs cultured with old MSC-derived EVs (Fig. 4b). An-
other ageing marker studied was LMNA, whose expres-
sion is increased in premature ageing conditions, as is
prelamin A [21]. An increase in the expression of the
three lamin isoforms was observed by western blot tech-
nique in young MSCs co-cultured with old MSC-derived
EVs, while old MSCs cultured with young MSC-derived
EVs showed decreased levels (Fig. 5a, b), with the high-
est levels being found after 6 days. All these results indi-
cated that EVs contained factors which either stimulated
or inhibited targets in the cells to which they were
added, consistent with the findings of Fierabracci et al.
[22]. As such, we evaluated the changes at the protein
levels and confirmed the influence of MSC-derived EVs
on senescence of MSCs in vitro. This discovery sug-
gested that old MSC-derived EVs contained “age-pro-
moting” factors [23], which may be responsible for the
age-associated decline in stem cells, self-renewal and
pluripotency, which are influenced by ageing. It was an
important concept in the understanding of the ageing
process and in developing EV-based therapies.
Fig. 6 Study of mTOR family in MSCs. a The histograms represent the gene expression of mTOR, Rictor and AKT normalised by HPRT, a housekeeping
gene, in old MSCs with or without young MSC-derived EVs at different times (2, 3 and 6 days). b The histograms represent the gene expression of
mTOR, Rictor and AKT gene expression normalised by HPRT, a housekeeping gene, in young MSCs with or without old MSC-derived EVs at different
times (2, 3 and 6 days). *P < 0.05 compared with the former group was considered statistically significant using Mann-Whitney U and Kruskal-Wallis
tests. c Western blot analysis of phospho-mTOR, Rictor and phospho-AKT from old MSCs with or without young MSC-derived EVs at different times (2,
3 and 6 days). d Western blot analysis of phospho-mTOR, Rictor and phospho-AKT from young MSCs with or without old MSC-derived EVs at different
times (2, 3 and 6 days). The molecular weight of each protein is shown on the left. One representative experiment is shown. The gels have been run
under the same experimental conditions. Control, MSCs cultured with growth medium without EVs; oMSC, MSCs from the old group; yMSC, MSCs
from the young group; oEV, MSC-derived EVs from the old group; yEV, MSC-derived EVs from the young group
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Therefore, mTOR pathway represents a potential
therapeutic target for improving defective, aged stem
cells [4, 24]. mTOR showed decreased expression at
the transcriptional (Fig. 6a) and post-transcriptional
(phosphor-mTOR; Fig. 6c) levels when young MSC-
derived EVs were incubated with old MSCs. By con-
trast, we found the opposite results at the transcrip-
tional (Fig. 6b) and post-transcriptional (Fig. 6d) levels
when old MSC-derived EVs were incubated in young
MSC cultures. Rictor did not show any variation in
old MSCs treated with young MSC-derived EVs at the
transcriptional level, and it was not detected at the
post-transcriptional level (Fig. 6a, c). It could be able
because the expression of Rictor in young MSCs is
very low, and it is corroborated at post-transcriptional
level (Fig. 6c). Young MSC-derived EVs produced a reduc-
tion in AKT gene and AKT expressions (Fig. 6a, c). We
observed that young MSC-derived EVs were more effect-
ive than old MSC-derived EVs in their influence on MSCs
in vitro, as reported by several authors [25], except in the
case of Rictor expression. The results obtained at the tran-
scriptional and post-transcriptional levels showed a similar
trend, although delayed in time, and this could be because
unique features of MSCs are controlled by a dynamic
interplay between extrinsic signalling pathways and regu-
lation by epigenetic events not studied in this model.
MiR-188-3p directly targets Rictor, as demonstrated by Li
et al. [26] and Gharibi et al. [27], preventing the develop-
ment of an age-related phenotype and maintaining MSC
morphology of early passage cells, with high clonogenic
frequency and enhanced proliferative capacity. Young
MSCs showed knockdown on treatment with the antagon-
ist of miR-188-3p (Fig. 7a) where miR-188-3p levels of the
expression were significantly decreased, as well as its ex-
pression level in transfected young MSC-derived EVs
(data not shown). These results were consistent with those
published by Zou et al. [28] where miR-188-3p showed
the same expression pattern in the cells as well as into
Fig. 7 Effect of inhibition of miR-188-3p in MSCs. a miR-188-3p expression in old MSCs and young MSCs transfected with mimic or miR-188-3p
inhibitor, as determined by RT-qPCR analysis normalised with the expression of U6 small nuclear RNA. b Rictor and AKT gene expressions using
RT-qPCR analysis normalised with the expression of HPRT in old MSCs treated with young MSC-derived EVs mimic used as a control and young
MSC-derived EVs miR188−/−. *P < 0.05 compared with control was considered statistically significant using Mann-Whitney U and Kruskal-Wallis
tests. c Rictor and phosphor-AKT levels in old MSCs treated with young MSC-derived EV mimic used as control and young MSC-derived EVs
miR188−/−, using western blot analysis normalised by the expression of β-actin. d Representative images (magnification, × 20) of senescence-
associated beta-galactosidase (SA-β-gal) staining of old MSCs with young MSC-derived EVs and with young MSC-derived EVs modified with miR-
188-3p inhibitor added to the culture media, showing a higher number of negative cells in young MSC-derived EVs miR-188−/−-treated cells in
the densitometry analysis of the staining signal (bottom). Control, MSCs cultured with growth medium without EVs
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their exosomes. Young MSC-derived EVs miR-188−/− in-
creased the expression of Rictor and decreased that of
AKT (Fig. 7b) at the transcriptional level, and phosphory-
lated forms of mTOR and AKT were confirmed by west-
ern blotting (Fig. 7c), accomplished with a significant
reduction of SA-β-gal staining-positive cells in old MSCs
treated with young MSC-derived EVs miR-188−/− versus
old MSCs treated only with regular young-derived EVs
(Fig. 7d). We produced an inhibition of phosphor-AKT in
old MSCs through the increase of Rictor expression, by
inhibition of miR-188-3p, which induced rejuvenation of
old MSCs, as evident by a reduction of their beta-
galactosidase staining. Therefore, bio-products from
MSCs, such as extracellular vesicles, represent a promising
new way of reprogramming resident cells in several dis-
eases, such as acute and chronic kidney disease [29], or fa-
cilitating wound healing by promoting collagen synthesis
and angiogenesis [30].
In conclusion, extracellular vesicles are a promising new
approach to reprogramming cellular lines, modifying the
expression of target families like mTOR involved in age-
ing, through their miR cargo.
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